NDTVCenter·
US Drafts Rules To Spare Pharma From Strictest China Investment Curbs: Report
Instead of applying a broad ban across the entire industry, the proposed regulations seek to apply restrictions in high-risk areas, including pathogens and biotechnology that could be used for weaponisation purposes.
Read at NDTV →



